You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market
- 2. Kexing Biopharm's New Cancer Drug Gets Peru Market Approval
- 3. Early prediction of colorectal adenoma risk: leveraging large-language model for clinical electronic medical record data
- 4. IGF2BP2 regulates gastric cancer radiotherapy resistance through HIF1α-mediated glycolysis
- 5. Cuproptosis as a therapeutic target in cancer: a Systematic Review and bibliometric analysis of the research landscape
- 6. Carrick Therapeutics Announces New Clinical Data Supporting Biomarker-driven Patient Selection for Samuraciclib (CDK7i) in Combination with SERDs in Hormone Receptor Positive Advanced Breast Cancer
- 7. NIH researchers discover tissue biomarker that may indicate higher risk of aggressive breast cancer development and death
- 8. Visualising the mechanics of hormone-driven gene activation: Insights into breast cancer
- 9. Synchronous papillary renal neoplasm with reverse polarity and membranous nephropathy: a rare case report
- 10. A simple approach to prevent skin damage from heat steam in robotic breast surgery
Last updated at 16:39 GMT
Hot News Makers
Health/Pharma Companies
- 9160.19
- 6968.33
- 4714.61
- 2584.69
- 2194.54
- 2186.36
- 1251.78
- 1068.42
- 1013.86
- 880.62
Drugs, Treatments, Trials
- 1554.96
- 1345.06
- 1036.64
- 809.65
- 335.13
- 297.34
- 272.71
- 189.76
- 107.95
- 79.90
Last updated at 16:10 GMT
